"Retina and Cataract: An election year primer.”
Date: 27/02/2019
Venue: Retina & Eye Consultants, Level 3,33 MacMahon St, Hurstville, NSW, 2220
Provider: Retina & Eye Consultants
Contact: Venus Singh, [E] venus.singh@retinaconsultants.com.au, [P] 02 95701622
Learning Objectives
- Review the pathophysiology of Proliferative Diabetic Retinopathy
- Review Treatment of Diabetic Retinopathy
- Review Recent Studies pertinent to the treatment of Proliferative Diabetic Retinopathy
- Review indications for surgical intervention for Proliferative Diabetic Retinopathy
- Appreciate differences between normal and pathologic OCTs
- Assess and interpret OCT findings in a clinical context
- Correlate symptoms, clinical findings and OCTs
- Be familiar with the factors which guide the choice of intraocular lens used in cataract surgery.
- Be aware of macular diseases which may influence the choice of intraocular lenses used in cataract surgery.
- Be aware of options for intraocular lens implants in patients with poor central vision.
- Recognise and name some medications that may have adverse retinal effects
- Be aware of different mechanisms of retinal toxicity
- Understand the importance of various screening tests in diagnosis and monitoring of retinal toxicity.
- How diet affects AMD
- Pathology of AMD
- New treatments for AMD
- Develop an approach to the patient with epiphora
- Understand the assessment and management of a patient with nasolacrimal duct obstruction
- Develop a deeper understanding of assessment and management of lower lid malpositions
Max points awarded: 6.25
Session Information
Name |
---|
Surgery for Proliferative Diabetic Retinopathy |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name |
---|
OCT Interpretation |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name |
---|
IOL Selection for Patients with Macular Disease |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
0.75 |
Name |
---|
"Interesting cases" |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.50 |
Name |
---|
“Update on Dietary Advice to minimise Macular Degeneration” |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name |
---|
Assessment and Management of the Watery Eye |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
---|---|---|---|---|
Surgery for Proliferative Diabetic Retinopathy | Face to Face with Assessment | No | No | 1.00 |
OCT Interpretation | Face to Face with Assessment | No | No | 1.00 |
IOL Selection for Patients with Macular Disease | Face to Face with Assessment | No | No | 0.75 |
"Interesting cases" | Face to Face with Assessment | No | No | 1.50 |
“Update on Dietary Advice to minimise Macular Degeneration” | Face to Face with Assessment | No | No | 1.00 |
Assessment and Management of the Watery Eye | Face to Face with Assessment | No | No | 1.00 |